BriaCell Therapeutics Corp. Share Price Nasdaq
Stocks
BCTX
CA1079303071
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 29/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 3.730 USD | +0.54% |
|
-8.35% | -47.54% |
| Market Cap | 2.99Cr 2.58Cr 2.41Cr 2.2Cr 4.15Cr 285.68Cr 4.17Cr 29Cr 11Cr 144.21Cr 11Cr 11Cr 478.17Cr | P/E 2024 |
-2.56x | P/E 2025 | -0.12x |
|---|---|---|---|---|---|
| Enterprise Value | 1.2Cr 1.04Cr 97.15L 88.68L 1.67Cr 114.92Cr 1.68Cr 12Cr 4.5Cr 58Cr 4.51Cr 4.42Cr 192.36Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
99.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.54% | ||
| 1 week | -8.35% | ||
| Current month | +8.43% | ||
| 1 month | +9.71% | ||
| 3 months | +2.47% | ||
| 6 months | -2.36% | ||
| Current year | -47.54% |
| 1 week | 3.45 |  | 4.1 |
| 1 month | 3.27 | | 4.18 |
| Current year | 2.6 | | 12.1 |
| 1 year | 2.6 | | 14.68 |
| 3 years | 2.6 | | 1,093.5 |
| 5 years | 2.6 | | 1,870.5 |
| 10 years | 2.6 | | 8,100.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Williams
CEO | Chief Executive Officer | 70 | 01/11/2016 |
Gadi Levin
DFI | Director of Finance/CFO | 54 | 01/02/2016 |
| Chief Tech/Sci/R&D Officer | 65 | 16/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
William Williams
BRD | Director/Board Member | 70 | 01/11/2016 |
| Chairman | 41 | 24/04/2019 | |
Rebecca Taub
BRD | Director/Board Member | 74 | 07/03/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.54% | -8.35% | - | - | 3.25Cr | |
| -1.59% | -3.35% | +52.37% | +93.70% | 6.95TCr | |
| -1.34% | -0.75% | +48.21% | +91.86% | 6.5TCr | |
| +0.30% | -0.69% | +52.56% | +10.23% | 2.65TCr | |
| -2.35% | -5.75% | -12.90% | +448.54% | 2.59TCr | |
| -8.37% | -12.43% | +2.08% | -16.71% | 2.56TCr | |
| -0.96% | +10.36% | +283.06% | +436.50% | 2.02TCr | |
| -0.51% | +0.23% | +35.77% | -18.70% | 2TCr | |
| -1.91% | -4.37% | +13.28% | +535.19% | 1.57TCr | |
| -1.47% | +0.68% | +45.51% | +143.08% | 1.35TCr | |
| Average | -1.77% | -1.93% | +57.77% | +191.52% | 3.13TCr | |
| Weighted average by Cap. | -1.93% | -1.50% | +53.73% | +151.51% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -47.91L -41.29L -38.71L -35.34L -66.57L -46Cr -66.78L -4.59Cr -1.79Cr -23Cr -1.8Cr -1.76Cr -77Cr | -2.63Cr -2.27Cr -2.13Cr -1.94Cr -3.66Cr -251.47Cr -3.67Cr -25Cr -9.84Cr -126.94Cr -9.88Cr -9.66Cr -420.92Cr |
| Net Debt | -9L -7L -7L -6L -11.98L -8.24Cr -12.02L -82.63L -32.24L -4.16Cr -32.37L -31.66L -14Cr | -1.79Cr -1.54Cr -1.44Cr -1.32Cr -2.48Cr -170.76Cr -2.49Cr -17Cr -6.68Cr -86Cr -6.71Cr -6.56Cr -285.81Cr |
Employees
16
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $3.730 | +0.54% | 2,34,936 |
| 27/26/27 | $3.710 | -7.94% | 3,95,216 |
| 26/26/26 | $4.030 | +6.90% | 2,81,152 |
| 25/26/25 | $3.770 | +8.96% | 6,71,139 |
| 24/26/24 | $3.460 | -14.99% | 87,17,166 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BCT Stock
- BCTX Stock
Select your edition
All financial news and data tailored to specific country editions
